Meridia Diet Drug Stroke Side Effects Injury Attorney

Injured by Meridia?

Meridia (generic: sibutramine hci monohydrate) has been linked to side effects such as rapid heart rate, increased blood pressure, heart disease, stroke, seizure and mental impairments. Meridia is a drug that is used to treat obesity by controlling appetite.

Italy has suspended the sale of weight-loss products containing sibutramine, marketed as Meridia in the U.S. by Abbott Laboratories. Italy's Health Ministry said on March 7, 2002 that it was immediately withdrawing all sibutramine products from the market due to 50 reports of health-related problems. Although Italy was the first country to take the drugs off the market, other nations' regulatory bodies have expressed concern about sibutramine. Britain's Drug and Therapeutics Bulletin, published by the Consumers' Association, warned that the weight-loss drug had limited benefits and unwanted side effects.

In addition to the risk of cardiovasular problems, seizures, and mental impairments, it is believed that two women have died as a result of complications from the drug. Abbott Laboratories estimates that 8.6 million people have used sibutramine-based drugs since they were approved in 1997.

If you or a loved one took Meridia and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.

MeridiaRSS Feed

FDA Refuses to Ban Meridia Despite Reports of Serious Side-Effects and Deaths Linked to the Diet Drug

Aug 18, 2005 | www.Newsinferno.com

The Food and Drug Administration (FDA) has refused to ban Abbott Laboratories’ prescription diet drug Meridia, despite numerous reports of elevated blood pressure, heart complications, and deaths associated with the medication. Complaints about Meridia were brought to the FDA by the consumer watchdog group, Public Citizen (http://www.citizen.org/).Public Citizen first petitioned for the removal of Meridia from the market in 2002 when Italian health authorities suspended the drug after...

FDA Refuses to Ban Meridia Despite Reports of Serious Side-Effects and Deaths Linked to the Diet Drug »

Woman's Death Highlights Risk of Herbal Diet Products

Aug 15, 2005 | The Standard

Slimming aids containing fenfluramine were banned in the US in 1997.A 53-year-old woman has died and hundreds of others may be risking their lives by turning to herbal diet products that contain unsafe western medical ingredients, the Department of Health has warned.The woman died recently after using herbal health products found to contain the substances fenfluramine and propranolol.Philippa Yu, executive officer of the Hong Kong Eating Disorders Association (HEDA), echoed the warning, saying...

Woman's Death Highlights Risk of Herbal Diet Products »

Five Brands of Risk

Dec 7, 2004 | Washington Post

It's been a tough couple of weeks for the U.S. Food and Drug Administration (FDA) and pharmaceutical companies. But it's also been difficult for the millions of people who are taking any of five medications cited as potentially dangerous at a Nov. 18 Senate hearing. That hearing was held to explore the FDA's record on warning people about drug risks. During his testimony, David J. Graham, associate director of the FDA's office of drug safety, said underpublicized safety risks of five drugs...

Five Brands of Risk »

Concern About Drug Safety Doesn't Stop With Vioxx

Nov 22, 2004 | USA TODAY

Doctors have been taking calls from anxious patients ever since a Senate hearing on Vioxx last week at which an FDA scientist expressed concerns about the safety of five other drugs on the market.That David Graham of the Food and Drug Administration's Office of Drug Safety named names was surprising. But to anyone who has kept up with the scientific literature and the drugs' evolving labels, the names themselves were not.Steven Galson, an FDA administrator, attempted to temper Graham's...

Concern About Drug Safety Doesn't Stop With Vioxx »

Medical Experts Weigh Safety In Using Five Drugs

Nov 19, 2004 | Knight Ridder

A day after an FDA official raised safety concerns about five widely prescribed medicines, doctors and patients had the same question: Should they still use the drugs? David Graham, the Food and Drug Administration's associate director of drug safety, testified before a Senate committee Thursday that not only had his agency not given enough weight to safety concerns about the recalled painkiller Vioxx, but he also said regulators should be looking closely at five other drugs. They are: Pfizer...

Medical Experts Weigh Safety In Using Five Drugs »

More Meridia News